Literature DB >> 28413501

USP39 regulates the growth of SMMC-7721 cells via FoxM1.

Xianwen Yuan1,2, Xitai Sun1,3, Xiaolei Shi1,2, Chunping Jiang1,2, Decai Yu1,2, Weiwei Zhang1,2, Yitao Ding1,2.   

Abstract

The present study investigated ubiquitin specific peptidase 39 (USP39) gene knockdown on SMMC-7721 cells in vitro and in vivo, and the role of USP39 in regulating the growth of hepatocellular carcinoma (HCC). Two small interfering RNAs (siRNA) were constructed, which targeted the USP39 gene and control sequences were synthesized and inserted into a pGCSIL-GFP lentiviral vector. The full length of USP39 cDNA was amplified by polymerase chain reaction (PCR) and cloned into pEGFP-N2, and the recombinant plasmids were transfected into cells. Knockdown efficiency and upregulation of USP39 was determined by reverse transcription-quantitative PCR and western blotting. The impact of USP39 on the growth of SMMC-7721 cells in vitro was examined using an MTT assay, colony formation, flow cytometry (FCM) and immunohistochemical staining. The impact of USP39 on the growth of SMMC-7721 cells in vivo was examined by assessing tumorigenicity in nude mice. Western blotting was performed to examine the mechanism of USP39 regulation on SMMC-7721 cell growth. Recombinant vectors containing specific and scrambled USP39 siRNA sequences were constructed and transfected into SMMC-7721 cells. USP39 knockdown inhibited cell proliferation and colony formation in SMMC-7721 cells, while upregulation of USP39 promoted the growth of tumor cells. FCM indicated that USP39 knockdown led to G2/M arrest and induced apoptosis in SMMC-7721 cells. USP39 knockdown inhibited xenograft tumor growth in nude mice and led to the downregulation of the transcription factor Forkhead Box M1 (FoxM1). Gene expression of FoxM1 targets, including polo-like kinase 1, cyclin B1 and centromere protein A also decreased following USP39 knockdown. The results suggest that knockdown of USP39 inhibits the growth of HCC in vitro and in vivo, potentially through the induction of G2/M arrest by regulating the pre-mRNA splicing of FoxM1.

Entities:  

Keywords:  Forkhead Box M1; G2/M arrest; USP39; hepatocellular carcinoma

Year:  2017        PMID: 28413501      PMCID: PMC5377580          DOI: 10.3892/etm.2017.4115

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  27 in total

Review 1.  Phosphorylation network dynamics in the control of cell cycle transitions.

Authors:  Daniel Fisher; Liliana Krasinska; Damien Coudreuse; Béla Novák
Journal:  J Cell Sci       Date:  2012-10-15       Impact factor: 5.285

Review 2.  Molecularly targeted therapy in hepatocellular carcinoma.

Authors:  Hung Huynh
Journal:  Biochem Pharmacol       Date:  2010-04-04       Impact factor: 5.858

3.  Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis.

Authors:  M Molinari; C Mercurio; J Dominguez; F Goubin; G F Draetta
Journal:  EMBO Rep       Date:  2000-07       Impact factor: 8.807

4.  Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events.

Authors:  C P De Souza; K A Ellem; B G Gabrielli
Journal:  Exp Cell Res       Date:  2000-05-25       Impact factor: 3.905

Review 5.  Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy.

Authors:  Augusto Villanueva; Beatriz Minguez; Alejandro Forner; Maria Reig; Josep M Llovet
Journal:  Annu Rev Med       Date:  2010       Impact factor: 13.739

6.  Molecular analysis of a novel winged helix protein, WIN. Expression pattern, DNA binding property, and alternative splicing within the DNA binding domain.

Authors:  K M Yao; M Sha; Z Lu; G G Wong
Journal:  J Biol Chem       Date:  1997-08-08       Impact factor: 5.157

7.  Usp39 is essential for mitotic spindle checkpoint integrity and controls mRNA-levels of aurora B.

Authors:  Renske J van Leuken; Mark P Luna-Vargas; Titia K Sixma; Rob M F Wolthuis; René H Medema
Journal:  Cell Cycle       Date:  2008-09-03       Impact factor: 4.534

Review 8.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

9.  Zebrafish usp39 mutation leads to rb1 mRNA splicing defect and pituitary lineage expansion.

Authors:  Yesenia Ríos; Shlomo Melmed; Shuo Lin; Ning-Ai Liu
Journal:  PLoS Genet       Date:  2011-01-13       Impact factor: 5.917

10.  Cdc25B and Cdc25C differ markedly in their properties as initiators of mitosis.

Authors:  C Karlsson; S Katich; A Hagting; I Hoffmann; J Pines
Journal:  J Cell Biol       Date:  1999-08-09       Impact factor: 10.539

View more
  7 in total

Review 1.  Research Progress of DUB Enzyme in Hepatocellular Carcinoma.

Authors:  Jie Zhao; Jinhui Guo; Yanan Wang; Qiancheng Ma; Yu Shi; Feng Cheng; Qiliang Lu; Wen Fu; Guangxiong Ouyang; Ji Zhang; Qiuran Xu; Xiaoge Hu
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

2.  USP39 facilitates breast cancer cell proliferation through stabilization of FOXM1.

Authors:  Zhenwang Zhang; Wu Liu; Xiajun Bao; Tian Sun; Jiawei Wang; Mengxi Li; Chao Liu
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

3.  USP39 regulates the cell cycle, survival, and growth of human leukemia cells.

Authors:  Chunxia Liu; Xiaojian Yao; Ming Li; Yaming Xi; Li Zhao
Journal:  Biosci Rep       Date:  2019-04-05       Impact factor: 3.840

4.  Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma.

Authors:  Wenkai Ni; Saiyan Bian; Mengqi Zhu; Qianqian Song; Jianping Zhang; Mingbing Xiao; Wenjie Zheng
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

5.  Knocking down USP39 Inhibits the Growth and Metastasis of Non-Small-Cell Lung Cancer Cells through Activating the p53 Pathway.

Authors:  Jiahui Yuan; Gongye Zhang; Xiaomei Li; Qiujuan Ma; Weipeng Cheng; Weiwei Wang; Bing Zhang; Tianhui Hu; Gang Song
Journal:  Int J Mol Sci       Date:  2020-11-25       Impact factor: 5.923

6.  High Expression of Ubiquitin-Specific Protease 39 and Its Roles in Prognosis in Patients with Hepatocellular Carcinoma.

Authors:  Yu Liao; Lin Li; Huabao Liu; Yi Song
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-27       Impact factor: 2.629

7.  Ubiquitin-specific peptidase 39 promotes human glioma cells migration and invasion by facilitating ADAM9 mRNA maturation.

Authors:  Yue Xiao; Wenjing Ma; Weiwei Hu; Qianqian Di; Xibao Zhao; Xingyu Ma; Xinyi Chen; Ping Sun; Han Wu; Zherui Wu; Weilin Chen
Journal:  Mol Oncol       Date:  2021-05-02       Impact factor: 6.603

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.